Literature DB >> 17305258

Otological toxicity after postoperative radiotherapy for parotid tumours.

S A Bhide1, K J Harrington, C M Nutting.   

Abstract

Radiotherapy is commonly used in the management of malignant parotid gland tumours that have adverse pathological risk factors after surgery. Radiation to the parotid bed is associated with predictable complications. In particular, the close proximity of the auditory apparatus, which receives a significant radiation dose, results in significant toxicity in a proportion of patients. Here we review auditory toxicity after radiation to the parotid bed.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17305258     DOI： 10.1016/j.clon.2006.11.007

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


  8 in total

Review 1.  Radiation therapy and hearing loss.

Authors:  Niranjan Bhandare; Andrew Jackson; Avraham Eisbruch; Charlie C Pan; John C Flickinger; Patrick Antonelli; William M Mendenhall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

Review 2.  Recent advances in radiotherapy.

Authors:  S A Bhide; C M Nutting
Journal:  BMC Med       Date:  2010-04-28       Impact factor: 8.775

3.  Prospective study on the dose distribution to the acoustic structures during postoperative 3D conformal radiotherapy for parotid tumors: dosimetric and audiometric aspects.

Authors:  Barbara A Jereczek-Fossa; Elena Rondi; Andrzej Zarowski; Alberto D'Onofrio; Daniela Alterio; Mario Ciocca; Livia Corinna Bianchi; Marco Krengli; Luca Calabrese; Mohssen Ansarin; Gioacchino Giugliano; Roberto Orecchia
Journal:  Strahlenther Onkol       Date:  2011-05-16       Impact factor: 3.621

4.  Postoperative [¹²⁵I] seed brachytherapy in the treatment of acinic cell carcinoma of the parotid gland: with associated risk factors.

Authors:  Ming-Hui Mao; Jian-Guo Zhang; Jie Zhang; Lei Zheng; Shu-Ming Liu; Ming-Wei Huang; Yan Shi
Journal:  Strahlenther Onkol       Date:  2014-04-29       Impact factor: 3.621

Review 5.  Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers.

Authors:  S A Bhide; K L Newbold; K J Harrington; C M Nutting
Journal:  Br J Radiol       Date:  2012-05       Impact factor: 3.039

6.  The incidence of radioepidermitis and the dose-response relationship in parotid gland cancer patients treated with 125I seed brachytherapy: incidence of radioepidermitis and the dose-response relationship.

Authors:  Ming-Hui Mao; Jian-Guo Zhang; Lei Zheng; Hong Gao; Jie Zhang; Shu-ming Liu; Ming-wei Huang; Yan Shi
Journal:  Strahlenther Onkol       Date:  2014-09-09       Impact factor: 3.621

7.  Lymphoepithelioma-like carcinoma of the salivary gland: is radiotherapy alone adequate?

Authors:  Orit Kaidar-Person; Abraham Kuten; Salem Billan
Journal:  Case Rep Otolaryngol       Date:  2011-11-02

8.  Evaluation of an automatic segmentation algorithm for definition of head and neck organs at risk.

Authors:  David Thomson; Chris Boylan; Tom Liptrot; Adam Aitkenhead; Lip Lee; Beng Yap; Andrew Sykes; Carl Rowbottom; Nicholas Slevin
Journal:  Radiat Oncol       Date:  2014-08-03       Impact factor: 3.481
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.